The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells

Journal of Cellular Physiology

Volumn 224, Issue 2, 2010, Pages 369-375

  Slupianek, Artur ^a   Yerrum, Smitha ^a   Safadi, Fayez F ^a   Monroy, M A ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANDROGEN; HISTONE H2AZ; LUCIFERASE; PROSTATE SPECIFIC ANTIGEN; SHORT HAIRPIN RNA; SNF 2 RELATED CBP ACTIVATOR PROTEIN; UNCLASSIFIED DRUG; ANDROGEN RECEPTOR; AR PROTEIN, HUMAN; HISTONE; HISTONE H2A.F Z; HISTONE H2A.F-Z; SMALL INTERFERING RNA; SRCAP PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL NUCLEUS; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENHANCER REGION; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HORMONE RESPONSE; HUMAN; HUMAN CELL; IN VIVO STUDY; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION; REPORTER GENE; TRANSIENT TRANSFECTION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY; PROMOTER REGION; PROSTATE; PROSTATE TUMOR; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ADENOSINE TRIPHOSPHATASES; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HISTONES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PROMOTER REGIONS, GENETIC; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTEIN BINDING; RECEPTORS, ANDROGEN; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ACTIVATION;

EID: 77953628913     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.22132     Document Type: Article

References (48)

1. Aranda A, Pascual A. 2001. Nuclear hormone receptors and gene expression. Physiol Rev 81:1269-1304. (Pubitemid 32606670)
2. Arnaldi L, Borra R, Maciel R, Cerutti J. 2005. Gene expression profiles reveal that DCN, DI01, DI02 are underexpressed in benign and malignant thyroid tumors. Thyroid 15:210-221. (Pubitemid 40418688)
3. Bao Y, Shen X. 2007. SnapShot: Chromatin remodeling complexes. Cell 129:632.e631-632.e632.
4. Cleutjens KBJM, van der Korput HAGM, van Eekelen CCEM, van Rooij HCJ, Faber PW, Trapman J. 1997. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol 11:148-161. (Pubitemid 27057428)
5. Cleutjens KBJM, van der Korput HAGM, van Eekelen CCEM, van Rooij HCJ, Faber PW, Trapman J. 1997. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter. Mol Endocrinol 11:148-161.
6. Collette L. 2008. Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials. Eur Urol 53:6-9. (Pubitemid 350166730)
7. Comuzzi B, Sadar MD. 2006. Proteomic analysis to identify novel therapeutic targets for the treatment of advanced prostate cancer. Cell Science 3:61-81.
8. Creyghton MP, Markoulaki S, Levine SS, Hanna J, Lodato MA, Sha K, Young RA, Jaenisch R, Boyer LA. 2008. H2AZ is enriched at polycomb complex target genes in ES cells and is necessary for lineage commitment. Cell 135:649-661.
9. Farris SD, Rubio ED, Moon JJ, Gombert WM, Nelson BH. 2005. Transcription-induced chromatin remodeling at the c-myc gene involves the local exchange of histone H2A.Z. J Biol Chem 280:25298-25303.
10. Gevry N, Chan HMLL, Livingston DM, Gaudreau L. 2007. p21 transcription is regulated by differential localization of histone H2A.Z. Genes Dev 21:1869-1881. (Pubitemid 47204927)
11. Gevry N, Hardy S, Jacques PE, Laflamme L, Svotelis A, Robert F, Gaudreau L. 2009. Histone H2A.Z is essential for estrogen receptor signaling. Genes Dev 23:1522-1533.
12. Ghosh AK, Majumder M, Steele R, Yaciuk P, Chrivia J, Ray R, Ray RB. 2000. Hepatitis C virus NS5A protein modulates transcription through a novel cellular transcription factor SRCAP. J Biol Chem 275:7184-7188. (Pubitemid 30146268)
13. Guillemette B, Gaudreau L. 2006. Reuniting the contrasting functions of H2A.Z. Biochem Cell Biol 84:528-535.
14. Haelens A, Tanner T, Denayer S, Callewaert L, Claessens F. 2007. The hinge region regulates DNAbinding, nuclear translocation, and transactivation of the androgen receptor. Cancer Res 67:4514-4523. (Pubitemid 46815103)
15. Heinlein CA, Chang C. 2002. Androgen receptor (AR) coregulators: An overview. Endocr Rev 23:175-200.
16. Hua S, Kallen CB, Dhar R, Baquero MT, Mason CE, Russell BA, Shah PK, Liu J, Khramtsov A, Tretiakova MS, Krausz TN, Olopade OI, Rimm DLKPW. 2008. Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol 4:188-202.
17. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ. 2007. Cancer statistics, 2007.CACancer J Clin 57:43-66.
18. Jenster G. 1999. The role of the androgen receptor in the development and progression of prostate cancer. Semin Oncol 26:407-421. (Pubitemid 29411449)
19. Kang Z, Pirskanen A, Janne OA, Palvimo JJ. 2002. Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J Biol Chem 277:48366-48371. (Pubitemid 35470792)
20. Koh SS, Chen D, Lee Y-H, Stallcup MR. 2001. Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem 276:1089-1098. (Pubitemid 32096532)
21. Lee HJ, Chang C. 2003. Recent advances in androgen receptor action. Cell Mol Life Sci 60:1613-1622. (Pubitemid 37041360)
22. Lee DK, Li M, Chang C. 2003. The second largest subunit of RNA polymerse II interacts with and enhances transactivation of the androgen receptor. Biochem Biophys Res Commun 302:162-169. (Pubitemid 36268935)
23. Li B, Pattenden SG, Lee D, Gutiérrez J, Chen J, Seidel C, Gerton J, Workman JL. 2005. Preferential occupancy of histone variant H2AZ at inactive promoters influences local histone modifications and chromatin remodeling. Proc Natl Acad Sci USA 102:18385-18390.
24. Link KA, Burd CJ, Williams E, Marshall TW, Rosson G, Henry E, Weissman B, Knudsen KE. 2005. BAF57 governs androgen receptor action and androgen-dependent proliferation through SWI/SNF. Mol Cell Biol 25:2200-2215. (Pubitemid 40354619)
25. Marshall TW, Link KA, Petre-Draviam CE, Knudsen KE. 2003. Differential requirement of SWI/SNF for androgen receptor activity. J Biol Chem 278:30605-30613. (Pubitemid 36994565)
26. McEwan IJ, Gustafsson JA. 1997. Interaction of the human androgen receptor transactivation functionwith the general transcription factor TFIIF. Proc Natl Acad Sci USA 94:8485-8490.
27. Mellor J. 2006. Dynamic nucleosomes and gene transcription. Trends Genet 22:320-329.
28. Metzger E, Wissmann M, Yin N, Muller JM, Schneider R, Peters AH, Gunther T, Buettner R, Schule R. 2005. LSD1 demethylates repressive histone marks to promote androgenreceptor- dependent transcription. Nature 437:436-439. (Pubitemid 41613508)
29. Monroy MA, Schott NM, Cox L, Chen JD, Ruh M, Chrivia JC. 2003. SNF2-related CBP activator protein (SRCAP) functions as a coactivator of steroid receptor-mediated transcription through synergistic interactions with CARM-1 and GRIP-1. Mol Endocrinol 17:2519-2528. (Pubitemid 37542214)
30. Park JH, Roeder R. 2006. GAS41 is required for repression of the p53 tumor suppressor pathway during normal cellular proliferation. Mol Cell Biol 26:4006-4016. (Pubitemid 43788005)
31. Pear W, Nolan G, Scott M, Baltimore D. 1993. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci USA 90:8392-8396.
32. Rayasam GV, Wendling O, Angrand PO, Mark M, Niederreither K, Song L, Lerouge T, Hager GL, Chambon P, Losson R. 2003. NSD1 is essential for early post-implantation development and has a catalytically active SET domain. EMBO J 22:3153-3163.
33. Rouleau N, Domaskyi A, Reeben M, Moilanen AM, Havas K, Kang Z, T O-H, Palvimo JJ, Janne OA. 2002. Novel ATPase of SNF-like protein family interacts with androgen receptor and modulates androgen dependent transcription. Mol Biol Cell 13:2106-2119.
34. Ruhl DD, Jin J, Cai Y, Swanson S, Florens L, Washburn MP, Conaway RC, Conaway JW, Chrivia JC. 2006. Purification of a human SRCAP complex that remodels chromatin by incorporating the histone variant H2A.Z into nucleosomes. Biochemistry 45:5671-5677. (Pubitemid 43673197)
35. Santin AD, Zhan F, Bellone S, Palmieri M, Cane S, Bignotti E, Anfossi S, Gokden M, Dunn D, Roman JJ, O'Brien TJ, Tian E, Cannon MJ, ohn Shaughnessy J, Jr., Sergio Pecorelli S. 2004. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: Identification of candidate molecular markers for ovarian cancer diagnosis and therapy. Int J Cancer 112:14-25.
36. Scanlan M, Gout I, Gordon C, Williamson B, Stockert E, Gure A, Jager D, Chen Y, Mackay A, O'Hare M, Old L. 2001. Humoral immunity to human breast cancer: Antigen definition and quantitative analysis of mRNA expression. Cancer Immun 1:4-21.
37. Strobeck MW, DeCristofaro MF, Banine F, Weissman BE, Sherman LS, Knudsen ES. 2001. The BRG-1 subunit of the SWI/SNF complex regulates CD44 expression. J Biol Chem 276:9273-9278. (Pubitemid 37385511)
38. Sun A, Tawfik O, Gayed B, Thrasher JB, Hoestje S, Li C, Li B. 2007. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers. Prostate 67:203-213. (Pubitemid 46185323)
39. Svotelis A, Gevry N, Gaudreau L. 2009. Regulation of gene expression and cellular proliferation by histone H2A.Z. Biochem Cell Biol 87:179-188.
40. Tsai MJ, O'Malley BW. 1994. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451-486.
41. Wang X, Yeh S, Wu G, Hsu CL, Wang L, Chiang T, Yang Y, Guo Y, Chang C. 2001. Identification and characterization of a novel androgen receptor coregulator ARA267- alpha in prostate cancer cells. J Biol Chem 276:40417-40423. (Pubitemid 37373179)
42. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, Woolf SH, Glick SN, Ganiats TG, Bond JH, Rosen L, Zapka JG, Olsen SJ, Giardiello FM, Sisk JE, Van Antwerp R, Brown-Davis C, Marciniak DA, Mayer RJ. 1997. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology 112: 594-642.
43. Wissmann M, Yin N, Muller JM, Greschik H, Fodor BD, Jenuwein T, Vogler C, Schneider R, Gunther T, Buettner R, Metzger E, Schule R. 2007. Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression. Nature Cell Biol 9:347-353.
44. Wong MM, Cox L, Chrivia J. 2007. The chromatin remodeling protein SRCAP is critical for deposition of the histone variant H2A.Z at promoters. J Biol Chem 282:26132-26139.
45. Xu J, Li Q. 2003. Review of the in vivo functions of the p160 steroid receptor coactivator family. Mol Endocrinol 17:1681-1692.
46. Yamane K, Toumazou C, Tsukada Y, Erdjument-Bromage H, Tempst P, Wong J, Zhang Y. 2006. JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell 125:483-495.
47. Zilberman D, Coleman-Derr D, Ballinger T, Henikoff S. 2008. Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks. 456:125-129.
48. Zucchi I, Mento E, Kuznetsov VA, Scotti M, Valsecchi V, Simionati B, Vicinanza E, Valle G, Pilotti S, Reinbold R, Vezzoni P, Albertini A, Dulbecco R. 2004. Gene expression profiles of epithelial cells microscopically isolated from a breast-invasive ductal carcinoma and a nodal metastasis. Proc Natl Acad Sci USA 101:18147-18152.